¼¼°èÀÇ ±â°ü³» Æ©ºê ½ÃÀå
Endotracheal Tubes
»óǰÄÚµå : 1773814
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 473 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,228,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,684,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

±â°ü³» Æ©ºê ¼¼°è ½ÃÀåÀº 2030³â±îÁö 26¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 20¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ±â°ü³» Æ©ºê ¼¼°è ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 4.8%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 26¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ÀÏ¹Ý ±â°ü³» Æ©ºê´Â CAGR 3.9%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á±îÁö 10¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °­È­ ±â°ü³» Æ©ºê ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 6.1%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 5¾ï 3,660¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 7.4%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ±â°ü³» Æ©ºê ½ÃÀåÀº 2024³â¿¡´Â 5¾ï 3,660¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 5¾ï 810¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 7.4%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 2.3%¿Í 4.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ±â°ü³» Æ©ºê ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

±â°ü³» Æ©ºê°¡ Ç¥ÁØ ICU Àåºñ ÀÌ»óÀÇ Á¸ÀçÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

±â°ü³» Æ©ºê ½ÃÀåÀº ÀÀ±Þ, ¼ö¼ú, ÁßȯÀÚ½Ç µî¿¡¼­ ±âµµ °ü¸®°¡ ÀÓ»óÀû ÃÖ¿ì¼± °úÁ¦·Î ¶°¿À¸£¸é¼­ ±Þ°ÝÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. °ú°Å¿¡´Â Ç¥ÁØ ¼Ò¸ðǰÀ¸·Î ¿©°ÜÁ³´ø ±â°ü³» Æ©ºê(ETT)´Â ±âµµÀÇ °³ÅëÀ» À¯ÁöÇϰí, ±â°èÀû ȯ±â¸¦ °¡´ÉÇÏ°Ô Çϸç, ÈíÀÎÀ» ¹æÁöÇÏ´Â µ¥ ÇʼöÀûÀÎ »ý¸í À¯Áö ÇÁ·ÎÅäÄÝÀÇ Áß¿äÇÑ ±¸¼º¿ä¼Ò·Î ¹ßÀüÇß½À´Ï´Ù. ±×¸®°í ÃÖ±Ù¿¡´Â º´¿ø Àü Áø·á ȯ°æÀ¸·Î È®´ëµÇ°í ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î È£Èí±âÁúȯ, ¿Ü»ó ¹× ¿Ü°ú ¼ö¼úÀÇ ºÎ´ãÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½Å·ÚÇÒ ¼ö ÀÖ°í ¾ÈÀüÇÏ¸ç ±â¼úÀûÀ¸·Î °­È­µÈ ±âµµ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿äµµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÆÒµ¥¹Í ÀÌÈÄ ÁßȯÀÚ Ä¡·á ÇÁ·ÎÅäÄÝÀÇ º¯È­·Î ÀÎÇØ ÀΰøÈ£Èí±â Áö¿ø¿¡¼­ ±â°ü³» Æ©ºêÀÇ Àü·«Àû ¿ªÇÒÀÌ ÀçÁ¶¸íµÇ°í ÀÖ½À´Ï´Ù. º´¿øµéÀº ÁßÁõ ARDS(±Þ¼º È£Èí°ï¶õ ÁõÈıº)¿Í Àú»ê¼ÒÇ÷ÁõÀ» °ü¸®Çϱâ À§ÇØ ±â°ü³» »ð°üÀÌ Áß½ÉÀÌ µÈ COVID-19ÀÇ ±Þ°ÝÇÑ Áõ°¡¿¡ ´ëÇÑ ±³ÈÆÀ» ¹ÙÅÁÀ¸·Î È£Èí Ä¡·á Àç°í¸¦ ÀçÁ¶Á¤Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² Àü½Å¸¶Ãë¿Í »ð°üÀÌ ÇÊ¿äÇÑ ¼±ÅÃÀû ¼ö¼úÀÇ Áõ°¡´Â Àü ¼¼°è ¼ö¼ú °Ç¼ö¸¦ ´õ¿í Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ±â°ü³» Æ©ºê ½ÃÀåÀº ´õ ÀÌ»ó »ç¿ë·®»Ó¸¸ ¾Æ´Ï¶ó ¼º´É, °¨¿° °ü¸®, ȯÀÚ ¾ÈÀü, ¿öÅ©Ç÷οì È¿À²¼º¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖÀ¸¸ç, ÀÇ·á ±â°üÀº ±â°ü³» Æ©ºê Á¶´ÞÀÇ ¿ì¼±¼øÀ§¸¦ Àç°ËÅäÇØ¾ß ÇÕ´Ï´Ù.

ÀÓ»ó ¹× ¿î¿µ»óÀÇ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ Á¦Ç° µðÀÚÀÎÀº ¾î¶»°Ô ÁøÈ­Çϰí Àִ°¡?

¿À´Ã³¯ÀÇ ±â°ü³» Æ©ºê´Â ÇÕº´ÁõÀ» ÁÙÀ̰í, Æí¾ÈÇÔÀ» Çâ»ó½Ã۸ç, ±¤¹üÀ§ÇÑ °¨¿° °ü¸® Á¶Ä¡¿¡ ºÎÇÕÇϵµ·Ï Á¤¹ÐÇÏ°Ô ¼³°èµÇ¾î ÀÖ½À´Ï´Ù. ½Å°æ¿Ü°ú ¹× À̺ñÀÎÈİú¿¡¼­ »ç¿ëµÇ´Â °­È­ Æ©ºê ¹× Àå°© Æ©ºêºÎÅÍ Àü±â ¸Þ½º¸¦ »ç¿ëÇÏ´Â ½Ã¼ú¿ë ·¹ÀÌÀú ³»¼º Æ©ºê¿¡ À̸£±â±îÁö, Á¦Ç° ±¸¼ºÀº ½Ã¼úÀÇ Æ¯¼öÇÑ ¿ä±¸¸¦ ÃæÁ·½Ã۱â À§ÇØ ´Ù¾çÈ­µÇ¾î ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¼º¹® ÇÏ ÈíÀÔ Æ÷Æ®°¡ ÀÖ´Â Ä¿ÇÁÇü Æ©ºê´Â º´¿ø³» °¨¿°ÀÇ ÁÖ¿ä ¹®Á¦ÀÎ ÀΰøÈ£Èí±â °ü·Ã Æó·Å(VAP)À» ÁÙÀÌ´Â µ¥ È¿°úÀûÀ̱⠶§¹®¿¡ ÁßȯÀڽǿ¡¼­ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Å×ÀÌÆÛ Ä¿ÇÁ¿Í Æú¸®¿ì·¹Åº ÄÚÆÃÀÌ Àû¿ëµÈ Æ©ºê´Â ±âµµÀÇ ¹ÐÆó¼ºÀ» ³ô¿© ÈíÀÎ ¹× Á¡¸· ¼Õ»óÀÇ À§ÇèÀ» ÁÙÀÔ´Ï´Ù.

¿î¿µ Ãø¸é¿¡¼­´Â ¼³Á¤ ½Ã°£°ú ÀÎÀû ¿À·ù¸¦ ÁÙÀ̱â À§ÇØ »çÀü Æ÷ÀåµÈ ¸ê±Õ ETT ŰƮ·ÎÀÇ ÀüȯÀ» º¼ ¼ö ÀÖ½À´Ï´Ù. ƯÈ÷ ȸÀüÀ²ÀÌ ³ôÀº ¿Ü°ú º´µ¿¿¡¼­´Â ¹«±Õ¼ºÀ» º¸ÀåÇÏ°í ±³Â÷ ¿À¿°À» ÃÖ¼ÒÈ­Çϱâ À§ÇØ ¸¹Àº Áö¿ª¿¡¼­ ÀÏȸ¿ë ¶Ç´Â ÀÏȸ¿ë ŸÀÔÀ» ¼±È£Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿Âµµ ¼¾¼­, Ä¿ÇÁ ¾Ð·Â ¸ð´ÏÅÍ, ½Ã°¢Àû »ð°ü º¸Á¶ ±â´ÉÀÌ ³»ÀåµÈ Æ©ºê´Â ÀÓ»óÀǰ¡ º¸´Ù Á¤È®ÇÑ »ð°üÀ» Çϰí, »ð°ü ÈÄ ÇÕº´ÁõÀ» ÁÙÀÌ´Â µ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº ÀÓ»ó °á°ú¸¦ °³¼±ÇÒ »Ó¸¸ ¾Æ´Ï¶ó ¾÷¹« È¿À²¼ºÀ» Çâ»ó½ÃÄÑ Ç°Áú°ú 󸮷® ¹× °¨¿° °ü¸®ÀÇ ±ÕÇüÀ» ¸ÂÃß°íÀÚ ÇÏ´Â Á¶´Þ ÆÀ¿¡°Ô ¸Å·ÂÀûÀ¸·Î ´Ù°¡¿É´Ï´Ù.

¼ö¿ä ´Ùº¯È­¸¦ ÃËÁøÇÏ´Â ÀÓ»ó ¿µ¿ª°ú ȯ°æÀº?

±â°ü³» Æ©ºê¿¡ ´ëÇÑ ¼ö¿ä´Â ´õ ÀÌ»ó ´ëÇü 3Â÷ º´¿ø¿¡ ±¹ÇѵÇÁö ¾Ê°í ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, ¿Ü»ó ´ëÀÀ À¯´Ö, ¿Ü·¡ ÀÀ±Þ ÀÇ·á µî ºü¸£°Ô È®´ëµÇ°í ÀÖÀ¸¸ç, COPD, õ½Ä, Æó¼â¼º ¼ö¸é¹«È£ÈíÁõ°ú °°Àº ¸¸¼º È£Èí±âÁúȯÀÇ Áõ°¡´Â ÀÔ¿øÀ²°ú ¼ö¼ú·üÀÇ Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Àü½Å¸¶Ãë°¡ ÇÊ¿äÇÑ ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ¿Í ´çÀÏ ¼ö¼úÀÇ ÀαⰡ ³ô¾ÆÁö´Â °Íµµ ½ÃÀåÀÇ Àúº¯À» ³ÐÈ÷°í ÀÖ½À´Ï´Ù. ¼Ò¾Æ ÀÇ·á ºÐ¾ß¿¡¼­´Â ƯÈ÷ ½Å»ý¾Æ ¹× ¹Ì¼÷¾Æ¸¦ À§ÇØ ¿¬·É¿¡ ¸Â´Â Å©±âÀÇ Æ©ºê°¡ ÇÊ¿äÇÏ¿© °íµµ·Î Àü¹®È­µÈ ¼ö¿ä ºÐ¾ß°¡ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù.

ÀÀ±Þ ÀÇ·á ¼­ºñ½º(EMS)¿Í ±º ¾ßÀü º´¿ø¿¡¼­´Â º´¿ø Àü ±âµµ ¾ÈÁ¤È­¸¦ À§ÇØ ÀÛ°í À¯¿¬ÇÏ¸ç ºü¸£°Ô Àü°³ÇÒ ¼ö ÀÖ´Â Æ©ºê°¡ Á¡Á¡ ´õ ¼±È£µÇ°í ÀÖ½À´Ï´Ù. ½Ã¾ß°¡ ÁÁÁö ¾Ê°Å³ª ¿òÁ÷ÀÓÀÌ ¸¹Àº ȯ°æ¿¡¼­µµ »ð°üÀÌ ¿ëÀÌÇÑ Æ©ºê´Â ¿Ü»ó ÇÁ·ÎÅäÄÝ¿¡¼­ ¿ì¼±ÀûÀ¸·Î »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ¸¶Ãë°ú Àü¹®ÀÇ¿Í ÁßȯÀÚ½Ç Àü¹®Àǵ鵵 º¸´Ù Áøº¸µÇ°í Á÷°üÀûÀÎ ±âµµ °ü¸® ¼Ö·ç¼ÇÀ» ¿øÇϰí ÀÖÀ¸¸ç, ÀÌ´Â ETT¿Í »ð°ü ½ºÅ¸ÀÏ·¯Æ®¸¦ ÅëÇÕÇϰųª ºñµð¿À Èĵΰæ°ú ȣȯµÇ´Â ÇÏÀ̺긮µå ÀåºñÀÇ °³¹ß·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¿Ü°ú, ±¸±Þ, ¼Ò¾Æ°ú, ÇöÀå ÀÇ·á µî ÀÌ·¯ÇÑ ½ÃÀå ´Ùº¯È­´Â ´ëÀÀ °¡´ÉÇÑ ½ÃÀåÀ» ³ÐÈ÷´Â µ¿½Ã¿¡ ±â¼ú Çõ½Å°ú Ä¿½ºÅ͸¶ÀÌ¡ÀÇ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­¿¡¼­ ¹«¾ùÀÌ ½ÃÀåÀ» ÁÖµµÇϰí Àִ°¡?

±â°ü³» Æ©ºê ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú Çõ½Å, ´ÙÇÐÁ¦Àû ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä, ¾ÈÀüÇÑ ±âµµ °ü¸® ¹æ¹ý·ÐÀ¸·ÎÀÇ Àüȯ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â ÁßȯÀڽǿ¡¼­ ÀΰøÈ£Èí±â °ü·Ã ÇÕº´ÁõÀ» ÁÙÀ̱â À§ÇØ ¼º¹®ÇÏ ÈíÀÎ ¹× ¿¬¼Ó Ä¿ÇÁ ¾Ð·Â ¸ð´ÏÅ͸µ ±â´ÉÀ» °®Ãá ÷´Ü ETTÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. Àü½Å ¸¶Ãë°¡ ÇÊ¿äÇÑ ¼ö¼úÀÇ Áõ°¡´Â ƯÈ÷ ½Å°æ¿Ü°ú, ¾Ç¾È¸é¿Ü°ú, ÈäºÎ¿Ü°ú ¼ö¼ú¿¡ ¸Â°Ô Á¶Á¤µÈ °­È­ Æ©ºê, ¿¹ºñ ¼ºÇü Æ©ºê, ·¹ÀÌÀú ³»¼º Æ©ºê¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ÃÖÁ¾ ¿ëµµ Ãø¸é¿¡¼­ º¼ ¶§, ¼Ò¾Æ ¹× ½Å»ý¾Æ ÀÇ·á ºÐ¾ß¿¡¼­ÀÇ »ç¿ë È®´ë´Â ¸¶ÀÌÅ©·Î »çÀÌÁî, ³ëÄ¿ÇÁ, ¼ÒÇÁÆ® ÆÁ Æ©ºêÀÇ ±â¼ú Çõ½Å¿¡ ÈûÀÔ¾î »õ·Î¿î °íºÎ°¡°¡Ä¡ ºÐ¾ß¸¦ °³Ã´Çϰí ÀÖ½À´Ï´Ù. ÇÑÆí, ¼±Áø±¹ ½ÃÀå¿¡¼­´Â ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ¿Í ´çÀÏ ¼ö¼úÀÇ È®´ë·Î ºü¸¥ ȸÀüÀ» Áö¿øÇÏ´Â ¸ê±Õ ÀÏȸ¿ë Æ©ºê ¼¼Æ®¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Áö¿ªº°·Î´Â µ¿³²¾Æ½Ã¾Æ, ¶óƾ¾Æ¸Þ¸®Ä«, ¾ÆÇÁ¸®Ä« ÀϺΠÁö¿ª°ú °°Àº ½ÅÈï ½ÃÀåÀÌ ±¹Á¦ ÀÇ·á ÀÚ±ÝÀÇ Áö¿øÀ» ¹Þ¾Æ ¼ö¼ú ¹× ¿Ü»ó ÀÎÇÁ¶ó ±¸Ãà¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, VAP °¨¼Ò ±â´ÉÀ» °®Ãá ETTÀÇ »ç¿ëÀ» ÃËÁøÇϰí, º´¿ø Àü ¹× ¼ö¼ú ÀüÈÄ ÀÇ·á¿¡¼­ »ð°ü ÇÁ·ÎÅäÄÝÀ» Ç¥ÁØÈ­ÇÏ´Â ÀÓ»ó °¡À̵å¶óÀÎÀÌ ±¸Á¶ÀûÀ¸·Î äÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÓ»óÀû Çʿ伺, ÀåÄ¡ÀÇ Çõ½Å¼º, ÃÖÁ¾ ¿ëµµÀÇ ´Ù¾çÈ­ µî ÀÌ·¯ÇÑ º¹ÇÕÀûÀÎ ¿äÀÎÀ¸·Î ÀÎÇØ ±â°ü³» Æ©ºê ½ÃÀåÀº ÇÁ¸®¹Ì¾ö ¹× ºñ¿ë Á᫐ ºÎ¹® ¸ðµÎ¿¡¼­ Àü ¼¼°èÀûÀ¸·Î Áö¼ÓÀûÀÎ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÎ¹®

Á¦Ç°(ÀÏ¹Ý ±â°ü³» Æ©ºê, °­È­ ±â°ü³» Æ©ºê, ¿¹ºñ ¼ºÇü ±â°ü³» Æ©ºê, ´õºí ·ç¸à ±â°ü³» Æ©ºê), Åõ¿© °æ·Î(±â°ü³», ±â°ü ºñ°­), ¿ëµµ(±ä±Þ Ä¡·á, Ä¡·á, ±âŸ), ÃÖÁ¾ ¿ëµµ(Ŭ¸®´Ð, º´¿ø, ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ, ±âŸ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Endotracheal Tubes Market to Reach US$2.6 Billion by 2030

The global market for Endotracheal Tubes estimated at US$2.0 Billion in the year 2024, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Regular Endotracheal Tube, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.0 Billion by the end of the analysis period. Growth in the Reinforced Endotracheal Tube segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$536.6 Million While China is Forecast to Grow at 7.4% CAGR

The Endotracheal Tubes market in the U.S. is estimated at US$536.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$508.1 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Endotracheal Tube Market - Key Trends & Drivers Summarized

Why Are Endotracheal Tubes More Than Just a Standard ICU Supply?

The endotracheal tube market is witnessing a sharp uptrend as airway management becomes a top clinical priority across emergency, surgical, and intensive care settings. While traditionally viewed as standard consumables, endotracheal tubes (ETTs) have evolved into critical components of life support protocols - essential in maintaining airway patency, enabling mechanical ventilation, and preventing aspiration. Their usage spans operating rooms, trauma centers, ICUs, emergency response systems, and increasingly in pre-hospital care environments. As the global burden of respiratory illnesses, trauma cases, and surgical interventions increases, so does the demand for reliable, safe, and technologically enhanced airway solutions.

Post-pandemic shifts in critical care protocols have also re-emphasized the strategic role of endotracheal tubes in ventilatory support. Hospitals are recalibrating their respiratory care inventory in response to lessons from COVID-19 surges, where endotracheal intubation became central to managing severe ARDS (acute respiratory distress syndrome) and hypoxemia. In parallel, the rise in elective surgeries - many of which require general anesthesia and intubation - is further driving global procedural volume. The market is no longer driven by volume alone but by performance, infection control, patient safety, and workflow efficiency, pushing institutions to reassess their endotracheal tube procurement priorities.

How Is Product Design Evolving to Address Clinical and Operational Challenges?

Today’s endotracheal tubes are being designed with precision features aimed at reducing complications, improving comfort, and aligning with broader infection control measures. From reinforced and armored tubes used in neurosurgery or ENT to laser-resistant tubes for procedures involving electrocautery, the product mix is diversifying to meet procedure-specific needs. Cuffed tubes with subglottic suction ports, for instance, are gaining adoption in ICUs due to their effectiveness in reducing ventilator-associated pneumonia (VAP), a major hospital-acquired infection concern. Tubes with tapered cuffs or polyurethane coatings offer better tracheal sealing and lower the risk of aspiration and mucosal damage.

From an operational perspective, the market is witnessing a shift toward preformed, pre-packaged, and sterile ETT kits that reduce setup time and human error. Single-use and disposable variants are preferred in many regions to ensure sterility and minimize cross-contamination, especially in high-turnover surgical units. Furthermore, tubes with integrated temperature sensors, cuff pressure monitoring, and visual intubation aids are helping clinicians achieve more accurate placements and reduce post-extubation complications. These innovations are not only improving clinical outcomes but also enhancing operational efficiency, making them attractive for procurement teams balancing quality with throughput and infection control.

Which Clinical Areas and Settings Are Driving Demand Diversification?

Demand for endotracheal tubes is no longer confined to large tertiary hospitals; it is rapidly expanding across outpatient surgery centers, trauma response units, and ambulatory emergency care. The increasing prevalence of chronic respiratory diseases such as COPD, asthma, and obstructive sleep apnea is contributing to higher hospitalization and surgical rates, all of which may necessitate intubation. The growing popularity of ambulatory surgical centers and day-care surgeries requiring general anesthesia is also expanding the market’s reach. In pediatric care, the need for age-specific tube sizes, especially for neonatal and preterm infants, is creating a highly specialized demand segment.

In emergency medical services (EMS) and military field hospitals, compact, flexible, and quick-deployment tubes are increasingly preferred for pre-hospital airway stabilization. Tubes that allow easy intubation in low-visibility or high-motion environments are being prioritized in trauma protocols. Anesthesiologists and intensivists are also calling for more advanced, intuitive airway management solutions, leading to the development of hybrid devices that combine ETTs with integrated intubation stylets or compatibility with video laryngoscopes. This clinical diversification - spanning surgical, critical care, pediatric, and field medicine - is broadening the addressable market while creating opportunities for innovation and customization.

What Is Driving the Market’s Upward Trajectory Across Segments and Regions?

The growth in the endotracheal tube market is driven by several factors directly tied to technology innovation, procedural demand across specialties, and the global shift toward safer airway management practices. One of the primary drivers is the increasing adoption of advanced ETTs with subglottic suction and continuous cuff pressure monitoring, aimed at reducing ventilator-associated complications in ICUs. The rising number of surgical procedures requiring general anesthesia is also fueling demand, particularly for reinforced, preformed, and laser-resistant tubes tailored for neurosurgery, maxillofacial, and thoracic procedures.

From an end-use standpoint, expanding application in pediatric and neonatal care - supported by innovations in micro-sized, uncuffed, and soft-tipped tubes - is unlocking new high-value segments. Meanwhile, the growth of ambulatory surgery centers and same-day procedures in developed markets is pushing demand for ready-to-use, sterile, disposable tube sets that support faster turnover. On the regional front, emerging markets such as Southeast Asia, Latin America, and parts of Africa are investing in surgical and trauma infrastructure, often backed by international health funding, thereby opening new procurement channels for basic and specialty ETTs. Additionally, clinical guidelines promoting the use of ETTs with VAP-reduction features and standardizing intubation protocols in pre-hospital and perioperative care are driving structured adoption. These cumulative drivers - combining clinical necessity, device innovation, and end-use diversification - position the endotracheal tube market for sustained global growth across both premium and cost-sensitive segments.

SCOPE OF STUDY:

The report analyzes the Endotracheal Tubes market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Regular Endotracheal Tube, Reinforced Endotracheal Tube, Preformed Endotracheal Tube, Double-lumen Endotracheal Tube); Administration Route (Orotracheal, Nasotracheal); Application (Emergency Treatment, Therapy, Others); End-Use (Clinics, Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â